Radiopharm Theranostics Limited (AU:RAD) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Radiopharm Theranostics Limited has confirmed that it marked a recent announcement as price sensitive, highlighting its potential impact on the company’s stock value. The company became aware of the information on December 5th and promptly prepared to release it, ensuring compliance with ASX listing rules. This proactive approach aims to maintain transparency and investor confidence amidst notable trading activity.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.